Tuesday, April 16, 2019

Ensysce Biosciences Names New CFO, COO

San Diego-based Ensysce Biosciences, a clinical phase, drug development company aiming at overcoming prescription drug abuse and overdose issues, said it has named a new CFO and COO this morning. According to the firm, it has named Kurt Schmidt as Chief Financial Officer, and Geoff Birkett as Chief Commercial Officer. Schmidt previously served as CFO of

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---